131 related articles for article (PubMed ID: 8180122)
1. Influence of changes in the concentration of sex hormone-binding globulin in human serum on the protein binding of the contraceptive steroids levonorgestrel, 3-keto-desogestrel and gestodene.
Kuhnz W; Schütt B; Woloszczak R
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):573-80. PubMed ID: 8180122
[TBL] [Abstract][Full Text] [Related]
2. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
[TBL] [Abstract][Full Text] [Related]
3. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
Kuhnz W; Pfeffer M; al-Yacoub G
J Steroid Biochem; 1990 Feb; 35(2):313-8. PubMed ID: 2308344
[TBL] [Abstract][Full Text] [Related]
4. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
Kuhnz W; Schütt B; Power J; Back DJ
Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
[TBL] [Abstract][Full Text] [Related]
6. Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Juchem M; Pollow K
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2171-83. PubMed ID: 2175153
[TBL] [Abstract][Full Text] [Related]
7. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
Hammond GL; Bocchinfuso WP; Orava M; Smith CL; van den Ende A; van Enk A
Contraception; 1994 Oct; 50(4):301-18. PubMed ID: 7813219
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
9. Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Nilsson B; von Schoultz B
Gynecol Obstet Invest; 1989; 27(3):151-4. PubMed ID: 2525511
[TBL] [Abstract][Full Text] [Related]
10. Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Phillips A; Hahn DW; McGuire JL
Steroids; 1990 Aug; 55(8):373-5. PubMed ID: 2122551
[TBL] [Abstract][Full Text] [Related]
11. Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives.
Hümpel M; Täuber U; Kuhnz W; Pfeffer M; Brill K; Heithecker R; Louton T; Steinberg B; Seifert W; Schütt B
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):329-33. PubMed ID: 2142574
[TBL] [Abstract][Full Text] [Related]
12. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
[TBL] [Abstract][Full Text] [Related]
13. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
Bergink EW; Hamburger AD; de Jager E; van der Vies J
J Steroid Biochem; 1981 Feb; 14(2):175-83. PubMed ID: 6451769
[TBL] [Abstract][Full Text] [Related]
14. Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol.
Ruokonen A; Käär K
Eur J Obstet Gynecol Reprod Biol; 1985 Jul; 20(1):13-8. PubMed ID: 3161762
[TBL] [Abstract][Full Text] [Related]
15. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
16. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Kloosterboer HJ; Vonk-Noordegraaf CA; Turpijn EW
Contraception; 1988 Sep; 38(3):325-32. PubMed ID: 3139361
[TBL] [Abstract][Full Text] [Related]
17. Clinical results with subcutaneous implants containing 3-keto desogestrel.
Olsson SE; Odlind V; Johansson E
Contraception; 1990 Jul; 42(1):1-11. PubMed ID: 2117514
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Crona N; Silfverstolpe G; Samsioe G
Contraception; 1984 Mar; 29(3):261-70. PubMed ID: 6234148
[TBL] [Abstract][Full Text] [Related]
19. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
Kuusi T; Nikkilä EA; Tikkanen MJ; Sipinen S
Atherosclerosis; 1985 Mar; 54(3):251-62. PubMed ID: 3158321
[TBL] [Abstract][Full Text] [Related]
20. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Odlind V; Milsom I; Persson I; Victor A
Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
